Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Radzikowska, E. Wiatr, R. Langfort, I. Bestry, M. Plodziszewska, K. Roszkowski (Warsaw, Poland). Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses. Eur Respir J 2009; 34: Suppl. 53, 743

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic pneumonia – Our own experience with diagnosis and treatment Source: Annual Congress 2012 - The good clinical practice: useful case report Year: 2012 Comorbidities – risk factors for relapsed pulmonary TB Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Treatment of sarcoidosis – pentoxifylline Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Surgical treatment of pulmonary sequestration – 15-years experience Source: Annual Congress 2010 - Congenital lesions and rare pathology Year: 2010 Erdosteine – A new drug in the treatment of chronic rhinosinusitis Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Drug interaction in tuberculosis treatment – The role of pharmacists Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Chronic necrotizing aspergillosis – review of 10 cases Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Pulmonary TB -diabetes melitus – an unfavorable association Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Risk factors for severe bronchiolitis – A retrospective study Source: Annual Congress 2012 - Paediatric respiratory epidemiology. Wheeze: where, how and why? Year: 2012 Causing pathogenes in the severest AECOPD – one year analysis Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Heliox administration in patients with COPD exacerbation – Technical aspects Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Oral glucocorticoid treatment of severe asthma – Current practice in the US Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Cryptogenic organising pneumonia – just a manifestation of community acquired pneumonia? A retrospective analysis from 1995 to 2004 Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary tuberculosis – Still a challenging diagnosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention Source: Annual Congress 2011 - Medical education Year: 2011 Chronic meningitis – a rare form of onset of tuberculosis infection in infants Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Destroyed lung secondary to tuberculosis – Surgical options Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 Haemoptysis in children – some respiratory causes Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009